Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38–Mitogen-activated protein Kinase–dependent apoptosis

Ayed M. Allawzi; Alexander Vang; Richard T. Clements; Bong Sook Jhun; Nouaying R. Kue; Thomas J. Mancini; Amy K. Landi; Dmitry Terentyev; Jin O-Uchi; Suzy A. Comhair; Serpil C. Erzurum; Gaurav Choudhary

doi:10.1165/rcmb.2016-0344OC

Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38–Mitogen-activated protein Kinase–dependent apoptosis

Ayed M. Allawzi, Alexander Vang, Richard T. Clements, Bong Sook Jhun, Nouaying R. Kue, Thomas J. Mancini, Amy K. Landi, Dmitry Terentyev, Jin O-Uchi, Suzy A. Comhair, Serpil C. Erzurum, Gaurav Choudhary

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

Hyperproliferative endothelial cells (ECs) play an important role in the pathogenesis of pulmonary arterial hypertension (PAH). Anoctamin (Ano)-1, a calcium-activated chloride channel, can regulate cell proliferation and cell cycle in multiple cell types. However, the expression and function of Ano1 in the pulmonary endothelium is unknown. We examined whether Ano1 was expressed in pulmonary ECs and if altering Ano1 activity would affect EC survival. Expression and localization of Ano1 in rat lung microvascular ECs (RLMVECs) was assessed using immunoblot, immunofluorescence, and subcellular fractionation. Cell counts, flow cytometry, and caspase-3 activity were used to assess changes in cell number and apoptosis in response to the small molecule Ano1 activator, Eact. Changes in mitochondrial membrane potential and mitochondrial reactive oxygen species (mtROS) were assessed using 5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcarbocyanine, iodide (mitochondrial membrane potential dye) and mitochondrial ROS dye, respectively. Ano1 is expressed in RLMVECs and is enriched in the mitochondria. Activation of Ano1 with Eact reduced RLMVEC counts through increased apoptosis. Ano1 knockdown blocked the effects of Eact. Ano1 activation increased mtROS, reduced mitochondrial membrane potential, increased p38 phosphorylation, and induced release of apoptosis-inducing factor. mtROS inhibition attenuated Eact-mediated p38 phosphorylation. Pulmonary artery ECs isolated from patients with idiopathic PAH (IPAH) had higher expression of Ano1 and increased cell counts compared with control subjects. Eact treatment reduced cell counts in IPAH cells, which was associated with increased apoptosis. In summary, Ano1 is expressed in lung EC mitochondria. Activation of Ano1 promotes apoptosis of pulmonary ECs and human IPAH-pulmonary artery ECs, likely via increased mtROS and p38 phosphorylation, leading to apoptosis.

Original language	English (US)
Pages (from-to)	658-667
Number of pages	10
Journal	American journal of respiratory cell and molecular biology
Volume	58
Issue number	5
DOIs	https://doi.org/10.1165/rcmb.2016-0344OC
State	Published - May 1 2018
Externally published	Yes

Bibliographical note

Funding Information:
This work was supported by Veterans Affairs Merit Awards 5IO1BX000711 and National Heart, Lung, and Blood Institute (NHLBI) 1R01HL128661 (G.C.), National Institutes of Health (NIH) grants 5R25GM083270 and 5T32GM077995 (A.M.A.), awards from American Heart Association (AHA) GRNT20460376 and National Institute of General Medical Sciences (NIGMS) U54GM115677 (R.T.C.), awards from NIH 1R01HL136757, 5P30GM1114750, AHA 16SDG27260248, Rhode Island Foundation grant 20164376, and American Physiological Society 2017 Shih-Chun Wang Young Investigator Award (J.O.-U.), NIH grant 5R01HL121796HL (D.T.), and by NIH grants U54GM115677 and 5P30GM1114750 (B.S.J.); the collection of human pulmonary arterial cells is supported by NIH grants HL060917 and HL081064.

Publisher Copyright:
Copyright © 2018 by the American Thoracic Society.

Keywords

Anoctamin-1
Apoptosis
Endothelium
Mitochondria
Pulmonary arterial hypertension

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1165/rcmb.2016-0344OC

OpenUrl availability

Full text

Cite this

Allawzi, A. M., Vang, A., Clements, R. T., Jhun, B. S., Kue, N. R., Mancini, T. J., Landi, A. K., Terentyev, D., O-Uchi, J., Comhair, S. A., Erzurum, S. C., & Choudhary, G. (2018). Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38–Mitogen-activated protein Kinase–dependent apoptosis. American journal of respiratory cell and molecular biology, 58(5), 658-667. https://doi.org/10.1165/rcmb.2016-0344OC

Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38–Mitogen-activated protein Kinase–dependent apoptosis. / Allawzi, Ayed M.; Vang, Alexander; Clements, Richard T. et al.
In: American journal of respiratory cell and molecular biology, Vol. 58, No. 5, 01.05.2018, p. 658-667.

Research output: Contribution to journal › Article › peer-review

Allawzi, AM, Vang, A, Clements, RT, Jhun, BS, Kue, NR, Mancini, TJ, Landi, AK, Terentyev, D, O-Uchi, J, Comhair, SA, Erzurum, SC & Choudhary, G 2018, 'Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38–Mitogen-activated protein Kinase–dependent apoptosis', American journal of respiratory cell and molecular biology, vol. 58, no. 5, pp. 658-667. https://doi.org/10.1165/rcmb.2016-0344OC

@article{d3564aad1514411d8f1ee37a4757570c,

title = "Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38–Mitogen-activated protein Kinase–dependent apoptosis",

abstract = "Hyperproliferative endothelial cells (ECs) play an important role in the pathogenesis of pulmonary arterial hypertension (PAH). Anoctamin (Ano)-1, a calcium-activated chloride channel, can regulate cell proliferation and cell cycle in multiple cell types. However, the expression and function of Ano1 in the pulmonary endothelium is unknown. We examined whether Ano1 was expressed in pulmonary ECs and if altering Ano1 activity would affect EC survival. Expression and localization of Ano1 in rat lung microvascular ECs (RLMVECs) was assessed using immunoblot, immunofluorescence, and subcellular fractionation. Cell counts, flow cytometry, and caspase-3 activity were used to assess changes in cell number and apoptosis in response to the small molecule Ano1 activator, Eact. Changes in mitochondrial membrane potential and mitochondrial reactive oxygen species (mtROS) were assessed using 5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcarbocyanine, iodide (mitochondrial membrane potential dye) and mitochondrial ROS dye, respectively. Ano1 is expressed in RLMVECs and is enriched in the mitochondria. Activation of Ano1 with Eact reduced RLMVEC counts through increased apoptosis. Ano1 knockdown blocked the effects of Eact. Ano1 activation increased mtROS, reduced mitochondrial membrane potential, increased p38 phosphorylation, and induced release of apoptosis-inducing factor. mtROS inhibition attenuated Eact-mediated p38 phosphorylation. Pulmonary artery ECs isolated from patients with idiopathic PAH (IPAH) had higher expression of Ano1 and increased cell counts compared with control subjects. Eact treatment reduced cell counts in IPAH cells, which was associated with increased apoptosis. In summary, Ano1 is expressed in lung EC mitochondria. Activation of Ano1 promotes apoptosis of pulmonary ECs and human IPAH-pulmonary artery ECs, likely via increased mtROS and p38 phosphorylation, leading to apoptosis.",

keywords = "Anoctamin-1, Apoptosis, Endothelium, Mitochondria, Pulmonary arterial hypertension",

author = "Allawzi, {Ayed M.} and Alexander Vang and Clements, {Richard T.} and Jhun, {Bong Sook} and Kue, {Nouaying R.} and Mancini, {Thomas J.} and Landi, {Amy K.} and Dmitry Terentyev and Jin O-Uchi and Comhair, {Suzy A.} and Erzurum, {Serpil C.} and Gaurav Choudhary",

note = "Funding Information: This work was supported by Veterans Affairs Merit Awards 5IO1BX000711 and National Heart, Lung, and Blood Institute (NHLBI) 1R01HL128661 (G.C.), National Institutes of Health (NIH) grants 5R25GM083270 and 5T32GM077995 (A.M.A.), awards from American Heart Association (AHA) GRNT20460376 and National Institute of General Medical Sciences (NIGMS) U54GM115677 (R.T.C.), awards from NIH 1R01HL136757, 5P30GM1114750, AHA 16SDG27260248, Rhode Island Foundation grant 20164376, and American Physiological Society 2017 Shih-Chun Wang Young Investigator Award (J.O.-U.), NIH grant 5R01HL121796HL (D.T.), and by NIH grants U54GM115677 and 5P30GM1114750 (B.S.J.); the collection of human pulmonary arterial cells is supported by NIH grants HL060917 and HL081064. Publisher Copyright: Copyright {\textcopyright} 2018 by the American Thoracic Society.",

year = "2018",

month = may,

day = "1",

doi = "10.1165/rcmb.2016-0344OC",

language = "English (US)",

volume = "58",

pages = "658--667",

journal = "American journal of respiratory cell and molecular biology",

issn = "1044-1549",

publisher = "American Thoracic Society",

number = "5",

}

TY - JOUR

T1 - Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38–Mitogen-activated protein Kinase–dependent apoptosis

AU - Allawzi, Ayed M.

AU - Vang, Alexander

AU - Clements, Richard T.

AU - Jhun, Bong Sook

AU - Kue, Nouaying R.

AU - Mancini, Thomas J.

AU - Landi, Amy K.

AU - Terentyev, Dmitry

AU - O-Uchi, Jin

AU - Comhair, Suzy A.

AU - Erzurum, Serpil C.

AU - Choudhary, Gaurav

N1 - Funding Information: This work was supported by Veterans Affairs Merit Awards 5IO1BX000711 and National Heart, Lung, and Blood Institute (NHLBI) 1R01HL128661 (G.C.), National Institutes of Health (NIH) grants 5R25GM083270 and 5T32GM077995 (A.M.A.), awards from American Heart Association (AHA) GRNT20460376 and National Institute of General Medical Sciences (NIGMS) U54GM115677 (R.T.C.), awards from NIH 1R01HL136757, 5P30GM1114750, AHA 16SDG27260248, Rhode Island Foundation grant 20164376, and American Physiological Society 2017 Shih-Chun Wang Young Investigator Award (J.O.-U.), NIH grant 5R01HL121796HL (D.T.), and by NIH grants U54GM115677 and 5P30GM1114750 (B.S.J.); the collection of human pulmonary arterial cells is supported by NIH grants HL060917 and HL081064. Publisher Copyright: Copyright © 2018 by the American Thoracic Society.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Hyperproliferative endothelial cells (ECs) play an important role in the pathogenesis of pulmonary arterial hypertension (PAH). Anoctamin (Ano)-1, a calcium-activated chloride channel, can regulate cell proliferation and cell cycle in multiple cell types. However, the expression and function of Ano1 in the pulmonary endothelium is unknown. We examined whether Ano1 was expressed in pulmonary ECs and if altering Ano1 activity would affect EC survival. Expression and localization of Ano1 in rat lung microvascular ECs (RLMVECs) was assessed using immunoblot, immunofluorescence, and subcellular fractionation. Cell counts, flow cytometry, and caspase-3 activity were used to assess changes in cell number and apoptosis in response to the small molecule Ano1 activator, Eact. Changes in mitochondrial membrane potential and mitochondrial reactive oxygen species (mtROS) were assessed using 5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcarbocyanine, iodide (mitochondrial membrane potential dye) and mitochondrial ROS dye, respectively. Ano1 is expressed in RLMVECs and is enriched in the mitochondria. Activation of Ano1 with Eact reduced RLMVEC counts through increased apoptosis. Ano1 knockdown blocked the effects of Eact. Ano1 activation increased mtROS, reduced mitochondrial membrane potential, increased p38 phosphorylation, and induced release of apoptosis-inducing factor. mtROS inhibition attenuated Eact-mediated p38 phosphorylation. Pulmonary artery ECs isolated from patients with idiopathic PAH (IPAH) had higher expression of Ano1 and increased cell counts compared with control subjects. Eact treatment reduced cell counts in IPAH cells, which was associated with increased apoptosis. In summary, Ano1 is expressed in lung EC mitochondria. Activation of Ano1 promotes apoptosis of pulmonary ECs and human IPAH-pulmonary artery ECs, likely via increased mtROS and p38 phosphorylation, leading to apoptosis.

AB - Hyperproliferative endothelial cells (ECs) play an important role in the pathogenesis of pulmonary arterial hypertension (PAH). Anoctamin (Ano)-1, a calcium-activated chloride channel, can regulate cell proliferation and cell cycle in multiple cell types. However, the expression and function of Ano1 in the pulmonary endothelium is unknown. We examined whether Ano1 was expressed in pulmonary ECs and if altering Ano1 activity would affect EC survival. Expression and localization of Ano1 in rat lung microvascular ECs (RLMVECs) was assessed using immunoblot, immunofluorescence, and subcellular fractionation. Cell counts, flow cytometry, and caspase-3 activity were used to assess changes in cell number and apoptosis in response to the small molecule Ano1 activator, Eact. Changes in mitochondrial membrane potential and mitochondrial reactive oxygen species (mtROS) were assessed using 5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimidazolylcarbocyanine, iodide (mitochondrial membrane potential dye) and mitochondrial ROS dye, respectively. Ano1 is expressed in RLMVECs and is enriched in the mitochondria. Activation of Ano1 with Eact reduced RLMVEC counts through increased apoptosis. Ano1 knockdown blocked the effects of Eact. Ano1 activation increased mtROS, reduced mitochondrial membrane potential, increased p38 phosphorylation, and induced release of apoptosis-inducing factor. mtROS inhibition attenuated Eact-mediated p38 phosphorylation. Pulmonary artery ECs isolated from patients with idiopathic PAH (IPAH) had higher expression of Ano1 and increased cell counts compared with control subjects. Eact treatment reduced cell counts in IPAH cells, which was associated with increased apoptosis. In summary, Ano1 is expressed in lung EC mitochondria. Activation of Ano1 promotes apoptosis of pulmonary ECs and human IPAH-pulmonary artery ECs, likely via increased mtROS and p38 phosphorylation, leading to apoptosis.

KW - Anoctamin-1

KW - Apoptosis

KW - Endothelium

KW - Mitochondria

KW - Pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=85046683620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046683620&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2016-0344OC

DO - 10.1165/rcmb.2016-0344OC

M3 - Article

C2 - 29100477

AN - SCOPUS:85046683620

SN - 1044-1549

VL - 58

SP - 658

EP - 667

JO - American journal of respiratory cell and molecular biology

JF - American journal of respiratory cell and molecular biology

IS - 5

ER -

Activation of anoctamin-1 limits pulmonary endothelial cell proliferation via p38–Mitogen-activated protein Kinase–dependent apoptosis

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this